Ischemic phlebitis and venous gangrene

Seventeen cases of ischaemising phlebitis and 5 of venous gangrene are reported. Attention is given to the aetiopathogenetic factors that lead to massive thrombosis and dramatic progression of the disease: depression of vascular heparin, polyglobulia, serious dysproteinaemia, marked involvement of t...

Full description

Saved in:
Bibliographic Details
Published inMinerva chirurgica Vol. 32; no. 7; p. 409
Main Authors Ferrante, G, Bracale, G C, Jovino, R, Gentile, M
Format Journal Article
LanguageItalian
Published Italy 15.04.1977
Subjects
Anticoagulants - therapeutic use
Blood Protein Disorders - complications
Dextrans - therapeutic use
Fibrinolytic Agents - therapeutic use
Gangrene - etiology
Humans
Ischemia - complications
Polycythemia - etiology
Thrombophlebitis - complications
Thrombophlebitis - therapy
Venous Insufficiency - complications
Online AccessGet more information

Cover

More Information
Summary:Seventeen cases of ischaemising phlebitis and 5 of venous gangrene are reported. Attention is given to the aetiopathogenetic factors that lead to massive thrombosis and dramatic progression of the disease: depression of vascular heparin, polyglobulia, serious dysproteinaemia, marked involvement of the arterial district, etc. Treatment may be medical or surgical, based on large doses of anticoagulants, low-weight dextrane and thrombolytic drugs, though the results expected are not always obtained. At present, early venous disobstruction with a Fogarty catheter, coupled with prolonged anticoagulant management is the best course. Prognosis is certainly better in ischaemia. When gangrene sets in, prognosis is particularly poor, even as far as survival is concerned, due to serious concomitant shock.
ISSN:0026-4733